31 Treatment of Infections in the Immunocompromised Host Flashcards

1
Q

Currently, a little more than half of all documented infections in neutropenic patients are caused by ___________pathogens.

A

Gram-positive pathogens

This change likely resulted from the popularity of semipermanent venous catheters and from the use of prophylactic regimens that are active against gram-negative rods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Of gram-positive pathogens, ________________are the most common

A

Coagulase-negative staphylococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bacteria increasing in frequency among neutropenic patients, especially in those receiving hematopoietic stem cell transplant, likely because of their higher incidence of mucositis.

A

Enterococcus and viridans group streptococci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Organism that are less common unless periodontal or gastrointestinal pathology coexists where they tend to be part of a polymicrobial process.

A

Anaerobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bacterial infections common among patients with Hodgkin lymphoma, other lymphomas, or chronic lymphocytic leukemia primarily suffer from impaired cell-mediated immunity and diminished antibody production

A

Encapsulated organisms such as Pneumococcus or Haemophilus, Listeria and Nocardia infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most frequently isolated fungal pathogen

A

Candida species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Serves as a reservoir for Candida, with infection resulting from translocation across damaged intestinal epithelium or broad-spectrum antibiotics.

A

Gastrointestinal tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Infections caused by angio-invasive molds

A

Aspergillus and mucormycosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endemic to the southwestern United States, in particular Arizona and the San Joaquin Valley in California.

A

Coccidioides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endemic in the Ohio and Mississippi River Valleys

A

Histoplasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A ubiquitous, endogenous fungus that may cause pneumonia in neutropenic patients and in those with defective cellmediated immunity.

A

Pneumocystis jiroveci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Virus-associated hemorrhagic cystitis caused by___________ common among hematopoietic stem cell transplant recipients.

A

BK virus and adenovirus i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Blood cultures should be done before initiation of antibiotic therapy, and periodically thereafter if fever persists.

Ideally, _____ sets of blood samples should be drawn, especially for the initial episode of fever.

A

Two sets of blood samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Current recommendations as initial empiric therapy for bacterial infections

A

Single-drug therapy with an antipseudomonal β-lactam

Piperacillin-tazobactam, imipenem, meropenem, cefepime, and ceftazidime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TRUE OR FALSE

Empiric gram-positive coverage is not routinely recommended among patients with febrile neutropenia but should be considered under certain circumstances

A

TRUE

Empiric gram-positive coverage is not routinely recommended among patients with febrile neutropenia but should be considered under certain circumstances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for empiric gram-positive coverage

A

Patients with evidence of central line infection, skin and soft tissue infection, or bacterial pneumonia, or who have a recent history of methicillin-resistant Staphylococcus aureus (MRSA) infection

Patients with hemodynamic compromise and/or critical illness caused by suspected infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Staphylococcus aureus (MRSA) infection are at increased risk for MRSA infection and should be started on empiric ____________.

A

Vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TRUE OR FALSE

Having an indwelling catheter without evidence of infection is an indication for gram-positive coverage.

A

FALSE

Having an indwelling catheter without evidence of infection is not an indication for gram-positive coverage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Among patients who are unstable or in whom antibiotic resistance is suspected, it is reasonable to add a second gram-negative antibiotic like

A

Aminoglycosides

Fluoroquinolones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

First-line agents for severe MRSA infections

A

Vancomycin, linezolid, and daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A commonly used alternative to vancomycin but causes thrombocytopenia

A

Linezolid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

A good alternative to vancomycin for bloodstream infections but should not be used for pneumonia because of inactivation by surfactant.

A

Daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Agents for vancomycin-resistant Enterococcus (VRE)

A

Linezolid and daptomycin

Quinupristin/dalfopristin**

**not active against Enterococcus faecalis and is further limited by its toxicity profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

First-line therapy for ESBL producing gram-negative bacteria

A

Carbapenems (imipenem, meropenem, ertapenem)

25
Q

When is empiric antifungal therapy should be considered in febrile patients

A

If empiric antibiotic therapy is not effective within 5 to 7 days.

26
Q

Preparation of Amphotericin that is less nephrotoxic

A

AmBisome (liposomal amphotericin B)

27
Q

The first-line treatment for mucormycosis

A

Liposomal amphotericin

28
Q

Approved for treatment of C albicans, Cryptococcus neoformans, and Coccidioides immitis

A

Fluconazole

It is less active against non-albicans Candida species and is completely inactive against Candida krusei.
It also lacks activity against Aspergillus.

29
Q

The first-line therapy against Aspergillus

A

Voriconazole

30
Q

Side effects of voriconazole

A

Visual abnormalities, hallucinations, and liver function test (LFT) abnormalities

31
Q

Has shown promise as salvage therapy for both invasive aspergillosis and mucormycosis

A

Posaconazole

32
Q

Unlike the other azoles (which cause QT prolongation), this azole actually causes QT shortening

A

Isavuconazole

33
Q

First-line agents for invasive Candida infections

A

Echinocandins

Caspofungin, micafungin, and anidulafungin

34
Q

Approved for first-line empirical use in febrile neutropenia or as salvage therapy for aspergillosis

A

Caspofungin

35
Q

Treatment for Pneumocystis jiroveci pneumonia (PCP)

A

High-dose trimethoprim-sulfamethoxazole

36
Q

Option for patients who are allergic to or otherwise intolerant of trimethoprim-sulfamethoxazole

A

Primaquine-clindamycin

37
Q

Active against HSV and, at higher doses, against VZV

A

Acyclovir

38
Q

Effective in treating herpes simplex and zoster infections and may be administered less frequently but are not available for intravenous administration

A

Famciclovir and valacyclovir

39
Q

Effective in treatment of CMV disease and are also active against herpes simplex

A

Ganciclovir, valganciclovir, and foscarnet

40
Q

Usually the first-line therapy against CMV but results in marrow suppression

A

Ganciclovir or valganciclovir

41
Q

Used to treat RSV pneumonia in immunocompromised patients

A

Ribavirin plus an adjunctive immunomodulator such as intravenous immunoglobulin

42
Q

Used if influenza A virus is suspected

A

Oseltamivir or zanamivir

43
Q

First-line therapy for tuberculosis

A

Rifampin, isoniazid, pyrazinamide, and ethambutol

44
Q

Treatment for Mycobacterium avium-intracellulare complex

A

Clarithromycin, rifabutin, and ethambutol

45
Q

Suggested duration of antimicrobials

A

US: Continue antibiotics until fever resolution and bone marrow recovery (ANC ≥0.5 × 109/L)

Europe: returning to a prophylactic regimen in select patients before the ANC reaches ≥0.5 × 109/L

46
Q

Type of infection with elevated serum alkaline phosphatase levels and the presence of multiple “bull’s eye” or “target” lesions in the liver on CT

A

Hepatosplenic candidiasis

47
Q

Treatment for immune reconstitution inflammatory syndrome

A

Glucocorticoids

48
Q

Most commonly isolated organism in indwelling catheter infections

A

Coagulase-negative Staphylococcus spp.

49
Q

If the catheter is to be retained, a ______-day course of antibiotics is recommended and antibiotic lock therapy should be strongly considered if feasible.

A

10- to 14-day

50
Q

TRUE OR FALSE

Gram-negative, S aureus, and fungal infections of the catheter usually does not necessitate its removal.

A

FALSE

Gram-negative, S aureus, and fungal infections of the catheter usually necessitate its removal.

Antibiotic therapy for at least 14 days is recommended.

51
Q

Risk stratification scores for outpatient therapy

A
  • Multinational Association of Supportive Care in Cancer (MASCC) index
  • Talcott’s rules
  • Clinical Index of Stable Febrile Neutropenia (CISNE) mode
52
Q

Current recommended outpatient antibiotic regimens

A

Fluoroquinolone (ciprofloxacin or levofloxacin) combined with amoxicillin-clavulanate or clindamycin (if the patient is penicillin-allergic)

53
Q

Fluoroquinolones that has more activity against Pseudomonas

A

Ciprofloxacin

54
Q

Fluoroquinolones that is more active against gram-positive organisms including viridans streptococci that are commonly involved in mucositis.

A

Levofloxacin

55
Q

Effective at preventing recurrent herpes simplex infections in patients receiving chemotherapy

A

Acyclovir , valacyclovir

56
Q

Recommended as postexposure varicella prophylaxis for high-risk, nonimmune patients

A

VZV immunoglobulin

57
Q

A new antiviral with a mechanism of action distinct from ganciclovir; importantly, it does not cause myelosuppression

A

Letermovir

58
Q

TRUE OR FALSE

Immunizations with killed vaccines such as influenza are recommended. Live-attenuated vaccines, such as measles, should be avoided during immunosuppression.

A

TRUE

Immunizations with killed vaccines such as influenza are recommended. Live-attenuated vaccines, such as measles, should be avoided during immunosuppression.